(Q22251226)

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Old and new controversies in the alternative treatment of attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Attention-deficit/hyperactivity disorder (ADHD) in the course of life

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD).

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Co-existing psychiatric problems in ADHD in the ADORE cohort.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Comorbidity of tic disorders & ADHD: conceptual and methodological considerations

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Psychosocial treatments for children with attention deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Advances in the Genetics and Neurobiology of Attention Deficit Hyperactivity Disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Attention-deficit/hyperactivity disorder: an overview of the etiology and a review of the literature relating to the correlates and lifecourse outcomes for men and women

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Evidence-based psychosocial treatments for children and adolescents with attention-deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

The genetics of attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

The outcome of group parent training for families of children with attention-deficit hyperactivity disorder and defiant/aggressive behavior

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Attention deficit/hyperactivity disorder: working the system for better diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Assessment and intervention for attention-deficit/hyperactivity disorder in the schools. Lessons from the MTA study

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Is there a relationship between attention deficit hyperactivity disorder and bipolar disorder?

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Developmental coordination disorder: associated problems in attention, learning, and psychosocial adjustment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

First-onset tics in patients with attention-deficit-hyperactivity disorder: impact of stimulants

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Family processes and treatment outcome in the MTA: negative/ineffective parenting practices in relation to multimodal treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Nutrition in the treatment of attention-deficit hyperactivity disorder: a neglected but important aspect

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Enhancements to the behavioral parent training paradigm for families of children with ADHD: review and future directions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Association of the dopamine receptor D1 gene, DRD1, with inattention symptoms in families selected for reading problems

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Controlled trial of cumulative behavioural effects of a common bread preservative

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

ADHD drugs and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

A decision tree and clinical paths for the assessment and management of children with ADHD.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

The use, misuse and diversion of prescription stimulants among middle and high school students.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

NIMH collaborative multisite multimodal treatment study of children with ADHD: I. Background and rationale.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Validity of DSM-IV ADHD predominantly inattentive and combined types: relationship to previous DSM diagnoses/subtype differences.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Comorbidity in ADHD: implications for research, practice, and DSM-V.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Diagnostic continuity between child and adolescent ADHD: findings from a longitudinal clinical sample

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Lowering the burden of suffering from child psychiatric disorder: trade-offs among clinical, targeted, and universal interventions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Validity of DSM-IV attention-deficit/hyperactivity disorder for younger children

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Stimulant treatment for children: a community perspective.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Oppositional defiant and conduct disorder: a review of the past 10 years, part I.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Multimodal treatment of ADHD in the MTA: an alternative outcome analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Oppositional defiant disorder with onset in preschool years: longitudinal stability and pathways to other disorders.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Stimulant medication effects in a summer treatment program among young children with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Patterns of psychopathology and dysfunction in clinically referred preschoolers

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Assessing the impact of parent and teacher agreement on diagnosing attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Do artificial food colors promote hyperactivity in children with hyperactive syndromes? A meta-analysis of double-blind placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Parent and teacher rating scales in the evaluation of attention-deficit hyperactivity disorder: contribution to diagnosis and differential diagnosis in clinically referred children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

ADHD: new pharmacological treatments on the horizon

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Treating attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Racism as a source of health disparity in families with children with attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Symptoms of attention-deficit/hyperactivity disorder following traumatic brain injury in children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

The consequences of attention-deficit/hyperactivity disorder in adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Racial differences in parental reports of attention-deficit/hyperactivity disorder behaviors

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

The comorbidity of ADHD in the general population of Swedish school-age children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

The Epidemiology of Asperger Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

The epidemiology of Asperger syndrome. A total population study

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Nonstimulant medications for the treatment of ADHD.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

The effects of a double blind, placebo controlled, artificial food colourings and benzoate preservative challenge on hyperactivity in a general population sample of preschool children

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

National trends in the prevalence of attention-deficit/hyperactivity disorder and the prescribing of methylphenidate among school-age children: 1990-1995.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Expressive writing difficulties in children described as exhibiting ADHD symptoms

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Central auditory processing ability in children with ADHD with and without learning disabilities.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Racial and ethnic differences in ADHD and LD in young school-age children: parental reports in the National Health Interview Survey

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Attention-deficit hyperactivity disorder subtypes and comorbid disruptive behaviour disorders in a child and adolescent mental health clinic

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Further evidence for the diagnostic continuity between child and adolescent ADHD

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Evaluating the evidence for and against the overdiagnosis of ADHD.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Beyond methylphenidate: nonstimulant medications for youth with ADHD.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Empirically supported psychosocial treatments for attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Prevalence and assessment of attention-deficit/hyperactivity disorder in primary care settings

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Use of practice guidelines in the primary care of children with attention-deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Stimulants and sudden death: what is a physician to do?

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021

Visuomotor perception in children with attention deficit hyperactivity disorder--combined type.

1 reference

https://api.crossref.org/works/10.1016%2FJ.PEDN.2008.01.003

7 January 2021